Loading...
The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape
SIMPLE SUMMARY: Interleukin-33 (IL-33) is often released from damaged cells, acting as a danger signal. IL-33 exerts its function by interacting with its receptor suppression of tumorigenicity 2 (ST2) that is constitutively expressed on most immune cells. Therefore, IL-33/ST2 signaling can modulate...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8268428/ https://ncbi.nlm.nih.gov/pubmed/34209038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133281 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|